MARKET INTRODUCTION
Genome editing (also called gene editing) is a group of technologies that give scientists the ability to change an organism's DNA. These technologies allow genetic material to be added, removed, or altered at particular locations in the genome.
MARKET DYNAMICS
Increasing prevalence of cancer and other genetic disorders, growing preference for personalized medicine, Increase in R&D expenditure and growth of biotechnology and pharmaceutical industries, are some of the factors propelling the growth of the genome editing market. However, high cost of genomic equipment may impede the market growth.
MARKET SCOPE
`
The "Global Gene Editing Service Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gene Editing Service Market with detailed market segmentation by, technology, application, end-use, and geography. The Global Gene Editing Service Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Gene Editing Service Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Global Gene Editing Service Market is segmented on the basis of technology, application and end-use. On the basis of technology, the Global Gene Editing Service Market is categorized into clustered regularly interspaced short palindromic repeats (CRISPR), transcription activator-like effector nuclease (TALEN), zinc finger nuclease (ZFN), and other technologies. Based on application, the market is segmented as cell line editing, animal genome editing, plant genome editing, others. Based on end-user the market is segmented into pharmaceutical companies and biotechnology companies, academics and government research institutes, clinical research organizations.
?
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Gene Editing Service Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gene Editing Service Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Gene Editing Service Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Gene Editing Service Market in these regions.
MARKET PLAYERS
The report covers key developments in the Gene Editing Service Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Gene Editing Service Market are anticipated to lucrative growth opportunities in the future with the rising demand for Gene Editing Service Market in the global market. Below mentioned is the list of few companies engaged in the Gene Editing Service Market.
The report also includes the profiles of key Gene Editing Service Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GenScript USA Inc.
- Horizon Discovery Group plc.
- Integrated DNA Technologies Inc.
- Lonza Group Ltd
- Merck & Co.
- New England Biolabs Inc.
- Origene Technologies Inc.
- Sangamo Biosciences Inc.
- Thermo Fisher Scientific Inc.
- Transposagen Biopharmaceuticals Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization `options in the existing study.